These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 964303)

  • 21. Measurement of metabolites of dopamine and 5-hydroxytryptamine in cerebroventricular perfusates of unanesthetized, freely-moving rats: selective effects of drugs.
    Nielsen JA; Moore KE
    Pharmacol Biochem Behav; 1982 Jan; 16(1):131-7. PubMed ID: 6173884
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Turnover of dopamine and serotonin and their metabolites in the striatum of aged rats.
    Venero JL; Machado A; Cano J
    J Neurochem; 1991 Jun; 56(6):1940-8. PubMed ID: 1709201
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Free and conjugated 3,4-dihydroxyphenylacetic acid and homovanillic acid in brain dopaminergic areas at basal state and after pipotiazine activation.
    Tavitian E; Peyrin L; Dalmaz Y; Favre R; De Haut M; Cottet-Emard JM
    J Neural Transm; 1986; 65(3-4):261-75. PubMed ID: 2872271
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regional rat brain levels of 3,4-dihydroxyphenylacetic acid and homovanillic acid: concurrent fluorometric measurement and influence of drugs.
    Westerink BH; Korf J
    Eur J Pharmacol; 1976 Aug; 38(2):281-91. PubMed ID: 954842
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An in vivo study of dopamine release and metabolism in rat brain regions using intracerebral dialysis.
    Sharp T; Zetterström T; Ungerstedt U
    J Neurochem; 1986 Jul; 47(1):113-22. PubMed ID: 3711893
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Active transport pumps of HVA and DOPAC in dopaminergic nerve terminals.
    Miyamoto JK; Uezu E; Terashima S
    Physiol Behav; 1991 Jan; 49(1):141-7. PubMed ID: 1850138
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of type A and B monoamine oxidase on the formation of 3,4-dihydroxyphenylacetic acid (DOPAC) in tissues from the brain of the rat.
    Garrett MC; Soares-da-Silva P
    Neuropharmacology; 1990 Oct; 29(10):875-9. PubMed ID: 2123970
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A kinetic analysis of the effects of beta-phenylethylamine on the concentrations of dopamine and its metabolites in the rat striatum.
    Sato S; Tamura A; Kitagawa S; Koshiro A
    J Pharm Sci; 1997 Apr; 86(4):487-96. PubMed ID: 9109054
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 3,4-Dihydroxyphenylacetic acid and homovanillic acid in rat plasma: possible indicators of central dopaminergic activity.
    Bacopoulos NG; Hattox SE; Roth RH
    Eur J Pharmacol; 1979 Jun; 56(3):225-36. PubMed ID: 477719
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of extracellular DOPAC, HVA and 5-HIAA in rat striatum in vivo by differential pulse voltammetry: effect of phencyclidine, haloperidol and their coadministration.
    Crespi F; Keane PE
    Pharmacol Res Commun; 1987 Sep; 19(9):639-49. PubMed ID: 2448834
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of drugs on the formation of homovanillic acid in the rat retina.
    Westerink BH; Korf J
    Eur J Pharmacol; 1976 Nov; 40(1):175-8. PubMed ID: 11106
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of neurotransmitters or drugs on the in vivo release of dopamine and its metabolites.
    Kito S; Shimoyama M; Arakawa R
    Jpn J Pharmacol; 1986 Jan; 40(1):57-67. PubMed ID: 2870204
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 3-Methoxytyramine and different neuroleptics: dissociation from HVA and DOPAC.
    Groppetti A; Parenti M; Galli CL; Bugatti A; Cattabeni F; Di Giulio AM; Racagni G
    Life Sci; 1978 Oct; 23(17-18):1763-8. PubMed ID: 31531
    [No Abstract]   [Full Text] [Related]  

  • 34. Formation and clearance of interstitial metabolites of dopamine and serotonin in the rat striatum: an in vivo microdialysis study.
    Cumming P; Brown E; Damsma G; Fibiger H
    J Neurochem; 1992 Nov; 59(5):1905-14. PubMed ID: 1383428
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhancement of haloperidol-induced increase in rat striatal or mesolimbic 3,4-dihydroxyphenylacetic acid and homovanillic acid by pretreatment with chronic methamphetamine.
    Toru M; Mataga N; Takashima M; Nishikawa T
    Psychopharmacology (Berl); 1981; 74(4):316-20. PubMed ID: 6794073
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Levels of HVA and DOPAC in mouse corpus striatum in the supersensitivity phase after neuroleptic treatment.
    Hyttel J
    J Neurochem; 1977 Jan; 28(1):227-8. PubMed ID: 833596
    [No Abstract]   [Full Text] [Related]  

  • 37. Further evaluation of the mechanism by which amphetamine reduces striatal dopamine metabolism: a brain dialysis study.
    Zetterström T; Sharp T; Ungerstedt U
    Eur J Pharmacol; 1986 Dec; 132(1):1-9. PubMed ID: 3816961
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetic and pharmacodynamic studies of chlorpromazine in rats: effect of chlorpromazine on dopamine and dopamine metabolite concentration in rat striatum.
    Sato S; Koitabashi T; Koshiro A
    Biol Pharm Bull; 1995 Jul; 18(7):990-5. PubMed ID: 7581256
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 2-Guanidinoethanol increased dopamine release and 3,4-dihydroxyphenylacetic acid content, but not homovanillic acid content in the rat brain: electroneurochemical and enzymological studies.
    Yokoi I; Kabuto H; Hukuyama K; Nishijima Y; Itoh T; Yufu K; Akiyama K; Mori A
    Neurochem Res; 1992 Jul; 17(7):735-40. PubMed ID: 1407269
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ischemia increases tissue and decreases extracellular levels of acid dopamine metabolites in the rat striatum: further evidence for active transport of metabolites.
    Phebus LA; Mincy RE; Clemens JA
    Life Sci; 1995 Feb; 56(13):1135-41. PubMed ID: 9001448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.